A wave of new studies is reshaping how we think about addiction, immunity, and disease treatment. Spanish researchers have drawn the first detailed “imbalance map” of the brain’s endocannabinoid system in people with alcohol‑use disorder, shedding light on why alcohol can hijack reward pathways. In China, a massive library of 400 immune‑related transcription factors—each tagged with a DNA barcode—enabled scientists to test thousands of gene combos at once, opening doors to rapid immune‑cell reprogramming. A long‑acting leuprorelin injection for advanced prostate cancer has cleared Phase III trials, promising safer, less frequent dosing for patients. Meanwhile, a novel oral fermentation system using montmorillonite particles can produce beneficial microbes directly in the gut, helping restore intestinal balance. The upcoming GB 38031‑2025 battery‑safety standard is prompting labs to upgrade testing protocols, a crucial step as electric‑vehicle demand soars. Other breakthroughs include: a new mechanism linking lipid changes in brain immune cells to cognitive loss in alcohol disorder; the discovery that the hormone EPO helps tumors evade immunity; and a protective role for apolipoprotein D in keeping the blood‑brain barrier intact after stroke. Researchers also uncovered how stomach‑derived vesicles trigger acute gastritis, mapped whole‑brain decision‑making activity at cellular resolution, identified gut‑virus “enterotypes” that influence Crohn’s disease severity, and revealed a long‑non‑coding RNA that throttles heat‑production in beige fat. Finally, a magnetic nanomotor driven by a rotating field can re‑program macrophages to fight cancer, offering a fresh physical‑immunotherapy approach.
Read more